FDA, Some Senators Voice Concern Over Drug-Patenting Process

September 15, 2021

Read about the biggest pharmaceutical developments and pricing stories from the past week in KHN’s Prescription Drug Watch roundup. FiercePharma: To Lower Drug Prices, Senate Leaders, FDA Urge U.S. Patent And Trademark Office To Alter Patent Processes The Senate and the FDA are appealing to the U.S. Patent and Trademark Office (USPTO) to examine how it can limit the ability of pharmaceutical companies to leverage patent strategies to extend their drug monopolies.

Read the source article at Kaiser Health News
2021-09-15 14:42:58

Share This Story!